Keywords
Endometriosis, exosome, macrophage, miR-210-3p, ATP5D
Posted Date: June 9th, 2023
DOI: https://doi.org/10.21203/rs.3.rs-3030329/v1
License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License
Page 2/22
Abstract
Background
Endometriosis development is associated with peritoneal immune microenvironment abnormality. However, the specic
mechanism is uncertain. Investigating peritoneal immune microenvironment regulation mechanisms could introduce novel
therapeutic strategies for effective endometriosis treatment.
Methods
Wound healing assay, Transwell, colony formation were carried out to assess cells invasion and proliferation. Western blotting
analysis and ELISA were used to evaluate cells resistance to progesterone. Endometriosis C57BL6 mouse model was
conducted to assess the impact of peritoneal inammatory environment and macrophage miR-210-3p on ectopic lesion
implantation and growth. miRNA and proteomics sequencing were carried out to verify the potential mechanisms inuencing
the development of endometriosis.
Results
Medium conditioned of peritoneal macrophages from patients with endometriosis, as well as the medium conditioned of
macrophages treated with uterine-derived exosomes of endometriosis patients, promoted the proliferation, invasion and
progesterone resistance of cells. Interestingly, Uterine-derived exosomes of endometriosis patients increased miR-210-3p
expression in peritoneal macrophages. In vivo experiments conrmed that macrophages lentivirally transduced with miR-210-
3p inhibitor can signicantly decrease the number and volume of endometriotic lesions. Mechanistically, miR-210-3p
signicantly induced M2 macrophage polarization by inhibiting the expression of ATP5D, and promoted cells migration.
Conclusions
Uterine-derived exosomes of endometriosis patients upregulated the expression of miR-210-3p in peritoneal macrophages to
inhibit ATP5D, driving macrophages polarization towards M2 and promoting the development of endometriosis.
Background
Endometriosis is a common, oestrogen-dependent, chronic gynaecological disorder associated with pelvic pain and infertility,
affecting about 10% of reproductive-aged women[1]. The development of endometriosis involves hormonal imbalances,
immunological, proinammatory, and proangiogenic processes[2]. As a result, the precise pathogenic mechanisms of
endometriosis are not well-identied.
At present, the widely accepted theory is Sampson's theory of retrograde menstruation[3]. It is not known why only 6–10% of
women develop endometriosis despite retrograde menstruation occurring in 76–90% of women[4]. An attractive hypothesis is
that the endometrial stromal cells (hESCs) containing stem cell characteristics or endometrium-derived mesenchymal stem
cells (EMSCs)[5–7] may be abnormally shed through the fallopian tube into the peritoneal cavity in affected women, leading to
the formation of ectopic implants in endometriosis. There are reports indicating that reuxed ectopic stromal stem cells display
diverse features from eutopic stromal stem cells attributable to local microenvironment differences in the abdominal cavity [8,
9]. Consequently, some scholars have proposed that the development of endometriosis may involve the interaction between
MSCs and peritoneal immune cells.
Although the pathogenesis of endometriosis remains elusive, growing evidence has demonstrated that it may be related to an
aberrant immune response[10, 11]. Peritoneal macrophages play a key role in the establishment and maintenance of
endometriosis by regulating the immune and peritoneal environments[12, 13]. In endometriosis, abnormal levels of cytokines,
Page 3/22
interferon, and macrophage colony-stimulating factor in peritoneal uid lead to functional scavenger receptor deciency in
peritoneal macrophages[14, 15]. This decrease in phagocytic activity may contribute to the growth of ectopic endometrial cells.
Additionally, based on their activation state and function, macrophages can be classied into 'classically activated' M1 and
'alternatively activated' M2. Bacci et al.[16] conrmed that patients with endometriosis mainly have peritoneal uid containing
M2-polarized macrophages. Moreover, the focus of endometriosis has a higher concentration of M2 macrophages than
surrounding tissues. Injection of M2-polarized macrophages into the peritoneal cavity of mice promotes the formation of large
ectopic lesions, while M1-polarized macrophages only produce small lesions, indicating that M2-polarized macrophages can
facilitate growth of ectopic lesions[17]. Our previous research found that[18] eutopic endometrial cells can alter the immune
phenotype of peritoneal macrophages. However, the mechanism by which eutopic endometrial cells regulate the peritoneal
immune microenvironment from a distance is unclear as they are located in the uterine cavity.
Exosomes[19] are a circular monolayer structure with a diameter of 40 ~ 100nm, which can carry a variety of proteins, mRNAs,
and miRNA. It is a carrier of natural intercellular information, which can remotely regulate the function of receptor cells and
participate in the processes of immunity, antigen presentation, cell migration, angiogenesis, and cell growth[20]. The effect of
exosomes on macrophage polarization has been conrmed in various disease states. Zhao et al.[21] demonstrated that
mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia -reperfusion injury via modication of the
polarization of M1 macrophages to M2 macrophages. Xin et al.[22] constructed a scaffold with mesenchymal stem cell-derived
exosomes to promote endometrium regeneration and fertility restoration through macrophage immune regulation. Sun et al.
[23] found that exosomes from endometrial stromal cells of endometriosis patients could induce macrophages into M2
phenotype, decreasing their phagocytic ability.
Studies have shown that endometrial exosomes released into the uterine cavity can reux into the peritoneal cavity and
communicate with other cells to inuence the implantation of ectopic endometrial lesions[24, 25]. Our hypothesis is that
uterine-derived exosomes can modulate peritoneal macrophages to create an appropriate environment for the attachment of
ectopic endometrial lesions. In this study, we investigated the specic mechanisms by which uterine-derived exosomes regulate
peritoneal macrophages to promote the development of endometriosis.
Methods
Clinical specimens
Patients who underwent laparoscopic surgery for ovarian endometriosis were enrolled in the EMs group (n = 30). Patients who
underwent surgical treatment for other benign gynecological diseases, such as simple ovarian cysts, uterine incision diverticula,
or tubal ligation were enrolled in the control group (n = 30). Samples of peritoneal uid, uterine uid, and normal endometrial
tissues were collected from all patients. All of the samples were collected at the time of surgery at the Second Xiangya Hospital
of Central South University. Informed consent was obtained from each patient, and the study was approved by the Medical
Ethics Committee of the Second Xiangya Hospital of Central South University (#2020-065). Endometrial tissue and peritoneal
uid were treated within 6 hours of collection, while the uterine uid was stored in a freezer at -80 ℃ after centrifugation. All of
the patients had normal ovulation with regular menstrual cycles, and none of the patients had received steroid hormonal
medications for at least 3 months.
Isolation of primary cells and cell culture
Normal endometrial tissues were minced and digested in F12/DMEM containing collagenase I(2.5mg/ml) and
deoxyribonuclease I(0.1mg/ml) at 37°C for 40 minutes. The dispersed cells were separated by ltration through a 40µm cell
strainer. The cells were plated onto 25cm2 Falcon tissue culture asks and maintained in F12/DMEM supplemented with 10%
fetal bovine serum (FBS) at 37°C in a humidied atmosphere containing 5% CO2. Endometrial stromal cells (hESCs) were
puried by adherent culture, and the cells were used between passages for 3–6.
Page 4/22
The peritoneal uid was collected, centrifuged, and recuperated with PBS. Then, it was layered on the same volume of Ficoll
and centrifuged for 20 minutes at 2000rpm and at room temperature. The cloud-like layer was collected and washed twice with
PBS before inoculating the cells in a 6-well plate, with a density of 1 × 106/well. They were cultured in RPMI1640 medium
containing 10% FBS for 2 hours to remove non-adherent cells. Only the remaining adherent cells were considered peritoneal
uid macrophages. After culturing for 24h-48h, the supernatant and RNA were collected.
Thp1 and RAW264.7 cells were purchased from National Collection of Authenticated Cell Cultures. These cells were cultured in
RPMI1640 or DMEM High-Glucose medium supplemented with 10% FBS and 1% penicillin/streptomycin.
Surface marker prole and differentiation capacity
The characteristics of the stem cells[7] were identied by ow cytometry. After 3 generations of culture, the hESCs cells were
incubated with labeled surface antibodies: PerCP-CyTM5.5 Mouse Anti-Human CD45, APC Mouse Anti-Human CD146, PE
Mouse Anti-Human CD140b on ice for 30 minutes. Then, the cells were resuspended in PBS for FCM analysis.
hESCs were inoculated in a 6-well plate and cultured in DEME/F12 medium for 24 hours until reaching 70% conuence. Then,
an osteogenic differentiation medium was used to induce osteogenesis. The culture medium was changed every 7 days, and
alizarin red staining solution was used to detect calcium deposition on the 28th day. Then, an osteogenic differentiation
medium was used to induce osteogenesis. The culture medium was changed every 7 days, and alizarin red staining solution
was used to detect calcium deposition on the 28th day.
Wound healing assay
The third generation of hESCs in the logarithmic growth phase were seeded into a 6-well plate with a density of 5 × 105
cells/well. When the cell density reached 80 to 90%, a scratch was made in the monolayer using a 100µl pipette tip in the
middle of each well. Wound healing within the same scratched line was then observed and photographed at specic time
points (0 h, 24 h, or 48 h). Each experiment was performed three times.
Transwell
5 × 104 cells were seeded into the upper Transwell chamber using an 8µm pore size lter membrane and culture medium
supplemented with 10% FBS. Macrophage conditioned medium was added to the lower chamber at a ratio of 1:1 as a
chemoattractant. The cells that had migrated to the lower surface of the lter were xed in a 4% paraformaldehyde and stained
with crystal violet for 30 minutes. The natural air-dried lter membrane was used to count the migrated cells. Three
independent experiments were conducted.
Colony Formation Assay
The third generation hESCs were digested and seeded directly in 6-well plates (3× 103 cells/well) for the colony formation
assay and cultured in the presence of 10% FBS at 37°C with 5% CO2. Two weeks later, the cells were xed with 4%
paraformaldehyde and stained with crystal violet for 30 minutes. Count the number of colonies with diameter > 0.5mm.
Isolation of exosomes from uterine uid
The uterine uid collected during the operation was thawed at room temperature and centrifuged at 3000 × g for 20min to
remove cells. Then, the supernatant is passed through a 0.22µm lter to remove cellular debris. The exosomes were extracted
by Exosome Purication kit-exoupur (ECHO BIOTECH, Beijing, China), then concentrated by ultralter tube at 30000 rpm for
30min. The isolated exosomes were characterized by transmission electron microscopy, nanoparticle tracking analysis (NTA)
and western blot.
Treatment of macrophages with uterine uid-derived exosomes
Uterine uid-derived exosomes were labeled using a PKH67 Fluorescent Cell Linker Kit (Sigma-Aldrich, Saint Louis, MO, USA) to
detect the direct transfer of the exosomes into macrophages (Thp1). The puried exosomes were resuspended in PBS and
Page 5/22
labeled with PKH67. PBS without exosomes was used as control. The internalization of exosomes was conducted by
incubating Thp1 cells at 37°C with a nal concentration of 100µg/ml. Fluorescent signals were detected after 48h.
Cell transfection
The miR-210-3p mimics, inhibitor and respective negative controls (scrambled oligos) were obtained from RiboBio. According
to the manufacturer's instructions, transfections were performed using Lipofectamine 3000.
Transfection of RAW264.7 with miR-210-3p by lentiviral vector
miR-210-3p short hairpin RNA lentivirus (miR-210-3p inhibitor) and corresponding negative control lentiviruses (miRNA-NC)
were purchased from Genechem Co. Ltd (Shanghai, China). Cells were infected with lentiviruses at 100 MOI (multiplicity of
infection) for 6h and replaced with fresh medium for another 48h. The green uorescent protein signal was detected by a
uorescence microscope and gene transfection eciency was veried by PCR.
Establishment of the endometriosis mouse model.
Six-week-old female nonpregnant C57BL6 (20g) were obtained from the Laboratory Animal Research Center of the Second
Xiangya Hospital of Central South University. All animal handling and experimental procedures were approved by the Animal
Experimental Ethics Committee of the Second Xiangya Hospital of Central South University (#20220059).
Donor mice were initially treated with estradiol benzoate (3µg/mouse) and sacriced after 7 days. The uterus was removed and
immediately placed in saline solution. The two uterine horns were excised and split longitudinally with a surgical blade, and the
endometrium was carefully separated from muscles. Each endometrium was identically processed and disrupted into
segments smaller than 1 mm. On the 0th day of modeling, the fragment was injected into the abdominal cavity of recipient
mice. Overall, segments of endometrium from one uterus were placed in 400µl PBS and injected into two recipient mice. The
mice were sacriced by cervical dislocation 28 days after endometrial tissue injection, measure and record the size and volume
of the lesions. In the experimental group, mice received intraperitoneal injections of 2mg/kg LPS, every 3 days. (control group,
injection of PBS).
FCM analysis
After euthanizing the animals, peritoneal cells were retrieved by peritoneal lavage with 7ml of ice-cold washing buffer PBS.
After shaking the mice, peritoneal cells were collected. CD16/32 was used to block Fc receptors, F4/80 and CD11b were used
as pan-macrophage markers, iNOS and CD206 were used to detect M1 and M2 macrophages. The peritoneal macrophages
were incubated with antibodies. After washing with PBS, the cells were resuspended in PBS for FCM analysis.
RNA extraction and quantitative real-time PCR
Total RNA was extracted using TRIzol reagent. RNA was reverse-transcribed into cDNA using the HiScript II Q RT SuperMix for
qPCR (+ gDNA wiper) (No. R223-01;Vazyme), followed by qRT-PCR using ChamQ Universal SYBR qPCR Master Mix (No. Q711-
02; Vazyme) under the following thermal cycling conditions: initial denaturation at 95°C for 30 s, followed by 40 cycles of 95°C
for 5 s and 60°C for 30 s, and lastly 95°C for 15 s, 60°C for 1 min, and 95°C for 15 s. All PCR primers were designed and
synthesized by Sangon Biotech (Shanghai, China; Supplemental table S1). The threshold cycle method (2 − ΔΔ CT) was used to
calculate the relative expression levels normalized to GAPDH levels.
Western blot analysis
The total protein was extracted, and the protein concentration was determined by BCA. The proteins separated via SDS-PAGE
and transferred to PVDF membranes, and then blocked in 5% non-fat milk at room temperature for 2h. The membranes were
incubated overnight at 4°C with primary antibodies. According to the manufacturer's instructions, HRP conjugated secondary
antibodies and ECL kits were used to detect immunoreactive protein.
TMT Proteomics
Page 6/22
Total proteins of Thp1 transfected with miR-210-3p were extracted and their concentrations were quantied by the BCA assay
(Thermo Fisher Scientic, Waltham, MA). Peptides were labeled with TMT according to the manufacturer's protocol. For each
sample, 2ug of total peptides were separated and analyzed with a nano UPLC(EASY nLC1200) coupled to a Q Exactive HFX
Orbitrap instrument (Thermo Fisher Scientic) with a nano electrospray ion source. Data dependent acquisition (DDA) was
performed in prole and positive mode with Orbitrap analyzer.
Statistical analysis
The data are presented as the mean ± SD from at least three independent experiments. Statistical signicance was measured
using Student’s t test (two-tailed). A value of p < 0.05 indicates that the difference was statistically. All statistical analyses were
performed with GraphPad Prism 8.0.
Results
Abdominal inammatory microenvironment promotes the developmentof endometriosis
Establishment of a mouse endometriosis model, and simulation of different abdominal environments by injecting LPS and
PBS into the peritoneal cavity. Typical endometriosis-like lesions were formed in the mesentery or peritoneum 28 days after
implantation (Fig. 1a, b). The results showed that the volume of lesions in LPS group was signicantly larger than that in PBS
group, and the number of lesions showed the same trend (Fig. 1c). We conducted immunocytochemical staining for Ki-67
(proliferation marker) and vimentin (mesenchymal marker) followed by uorescence microscopy, and then observed that
abdominal inammation signicantly promoted the proliferation of endometrial stromal cells (Fig. 1d). At the same time, the
peritoneal uid of mice was collected for FCM analysis, it was found that the number of macrophages in LPS group was more
than that in PBS group, and M2 macrophages were dominant in both groups (Fig. 1e, f).
Peritoneal macrophages promote the proliferation and migration ofhESCs
Primary isolated hESCs expressed high levels of mesenchymal stem cell surface markers CD140b and CD146, and have the
potential for osteogenic and adipogenic differentiation (Supplemental Fig. 1a, b, c).
Peritoneal uid macrophages conditioned medium from patients with endometriosis (EMs) and patients without endometriosis
(Control) was used to interfere with hESCs. As shown in Fig. 2a, b, the results of wound healing assays and transwell migration
were performed to assess the inuence of macrophages on the migration of hESCs. As expected, macrophages from EMs
remarkably enhanced the migration capacity of hESCs. In addition, Western blot analysis (Fig. 2c, d) showed that compared to
the Control group, macrophages from EMs enhanced the expression of MMP9, MMP2 and N-Cadherin in hESCs. Subsequently,
FCM analysis and colony formation revealed that macrophages from EMs promoted the proliferative capacity of hESCs
(Fig. 2e, f).
To assess the inuence of macrophages on progesterone resistance of hESCs, we induced decidualization in vitro. Then we
examined the expression of estrogen (ER) and progesterone receptors (PR) in hESCs (Fig. 2g). Western blot analysis revealed
that peritoneal macrophages in patients with endometriosis reduced the expression of PR and epithelial marker E-cadherin and
enhanced the expression of mesenchymal marker N-Cadherin, which means that the differentiation ability of hESCs into
epithelial cells and decidualization was impaired. Consistent with the ndings, ELISA result showed (Fig. 2h) macrophages
from EMs decreased the expression of the decidualization markers IGFBP-1 in hESCs.
The effect of macrophages treated with exosomes on hESCs
EMs-exosomes (EMs-exo) from uterine uid of patients with endometriosis and Control-exosomes (Control-exo) from uterine
uid of patients without endometriosis showed similar characteristics of 100nm diameter, biconcave morphological features
Page 7/22
(Fig. 4a, b), and positive staining for exosomal makers TSG101, HSP70 and CD63(Fig. 4c). To elucidate the role of exosomes in
the macrophages, we used the Thp1 cell line as model of macrophages in vitro. The exosomes were labeled with PKH67 and
incubated with the macrophages. Uterine uid-derived exosomes with green uorescence were observed in the macrophages
(Fig. 4d). The results show that we successfully extracted uterine-derived exosomes and that macrophages can phagocytose
uterine-derived exosomes.
To investigate the function of macrophages treated with uterine-derived exosomes in hESCs. Thp1 were incubated with EMs-
exo and Control-exo for 48 hours, conditioned medium was collected and co-cultured with hESCs. Wound healing assays and
transwell assays revealed that EMs-exo group enhanced the migration of hESCs (Fig. 3a, b). Similarly, western blot analysis
showed that EMs-exo group increased the protein level of MMP9, MMP2 and N-Cadherin in hESCs (Fig. 3c, d). Moreover, FCM
analysis and colony formation indicated that compared to the Control-exo group, EMs-exo group promoted the proliferative
capacity of hESCs (Fig. 3e, f).
Furthermore, co-culturing EMs-exo conditioned medium with hESCs resulted in a downregulation of PR and E-cadherin
expression and an upregulation of N-cadherin in hESCs (Fig. 3g). Similarly, ELISA results showed that the secretion of IGFBP1
in hESCs was signicantly decreased in the EMs-exo group compared to the control group (Fig. 3h). These results suggested
that macrophages co-incubated with EMs-exo can promote the proliferation and migration of hESCs, resulting in progesterone
resistance and impairs decidualization.
miR-210-3p is overexpressed in macrophages treated with EMs-exo
To assess endometriosis-induced changes in the expression of exosomal miRNAs, we conducted sequencing of small RNAs
from endometriosis and non-endometriosis uterine-derived exosomes and eutopic endometrium, 9 differentially expressed
miRNAs were identied in exosomes, while 22 differentially expressed miRNAs were identied in endometrium. The miRanda
and TargetScan databases were used to predict the target genes of the differentially expressed miRNAs. Functional enrichment
analysis showed that the target genes of exosomal miRNA were mainly involved in the positive regulation of macrophage
differentiation, cytokine activity, ATP binding and glycogen metabolic process (Supplemental Fig. 2a, b). miR-210-3p expression
was signicantly upregulated in uterine-derived exosomes and eutopic endometrium from patients with endometriosis (Fig. 4e,
f), and qRT-PCR results also conrmed that it was markedly elevated in EMs-exo and eutopic endometrium[26]. Therefore, we
selected this miRNA for further analyses. Notably, as shown in Fig. 4g, miR-210-3p levels were signicantly higher in peritoneal
uid macrophages from endometriosis, compared with control group. Similarly, qRT-PCR results also conrmed that miR-210-
3p expression of Thp1 was obviously upregulated after EMs-exo treatment for 48h (Fig. 4h).
Based on the above results, we speculated that the uterine-derived exosomes of patients with endometriosis may promote the
development of endometriosis by upregulating the expression of miR210-3p in macrophages.
miR-210-3p promotes the proliferation and migration of hESCs in vitro
To clarify the effect of miR-210-3p on endometriosis, we rst silenced miR-210-3p by transfecting miR-210-3p inhibitor in Thp1.
Next, transwell migration and wound healing assays were performed to assess whether silenced miR-210-3p could reverse the
effect of peritoneal macrophages on the migration of hESCs. As shown in Fig. 5a, b, c, d, the low-expression of miR-210-3p
inhibited the migration capacity in hESCs. Subsequently, the results of colony formation and FCM assays revealed that the low-
expression of miR-210-3p in macrophages inhibited the proliferative capacity of hESCs (Fig. 5e, f). Western blot analysis
revealed that downregulating miR-210-3p enhanced the expression of epithelial marker E-cadherin and reduced the expression
of mesenchymal marker N-cadherin (Fig. 5g). The results showed that the ability of mesenchymal stem cells to differentiate
into epithelial cells was enhanced and the decidualization ability was improved after the inhibition of macrophage miR-210-3p,
and the decidualization marker IGFBP1 showed the same trend (Fig. 5h). These results suggested that inhibiting the expression
of miR-210-3p in macrophages can inhibit the migration and proliferation of hESCs, and improve the progesterone resistance
of hESCs.
miR-210-3p promotes the development of endometriosis in vivo
Page 8/22
Macrophage-depleting liposomes containing clodronate were used to deplete mouse peritoneal macrophages, then the miR-
210-3p of the mouse macrophage cell line RAW264.7 was knocked out using a lentivirus and intraperitoneally injected (Fig. 6a).
At sacrice, 28 days after intraperitoneal injection of syngeneic endometrial tissue, lesions had developed in all mice (Fig. 6b,
c). Endometriotic lesions with low-expression of miR-210-3p in mouse macrophages were signicantly bigger, which was
reected by their total volume and number (Fig. 6d). Immunouorescent staining of Ki-67 and vimentin were performed that
downregulation of miR-210-3p in macrophages inhibited the proliferation capacity of endometrial stromal cells (Fig. 6e). These
Results
implied that inhibiting miR-210-3p in macrophages effectively protected mice from endometriosis, and show that miR-
210-3p may be a valuable biomarker for non-invasive diagnosis and treatment of endometriosis.
miR-210-3p induces M2 macrophage polarization by ATP5D
To identify the molecular mechanism of miR-210-3p in macrophages, we transfected miR-210-3p mimics and inhibitors, and
then conducted proteomic sequencing. According to the results, we identied a total of 360 differentially expressed proteins
between miR-210-3p overexpression and the control group, and 37 differentially expressed proteins between miR-210-3p
underexpression and the control group.(Fig. 7a, b). Subsequently, functional analysis of the differential proteins was
performed. It was found that inhibition of miR-210-3p mainly affected ATP metabolic pathways, such as oxidative
phosphorylation pathway, ATP metabolism and ATP synthase activity (Supplemental Fig. 3b, d). KEGG showed that miR-210-
3p overexpression mainly affected immunoinammatory pathways (Supplemental Fig. 3a, c), such as IL-17 signaling pathway,
TNF signaling pathway and Nod-like receptor signaling pathway. We screened out differential proteins with consistent
expression trends in the two groups (Fig. 7c), and found that the expression of ATP5F1D, FAU and MST1L was inhibited in
macrophages when miR-210-3p was overexpressed, while the three proteins were up-regulated in macrophages when miR-210-
3p was underexpressed.
The qRT-PCR and WB results conrmed that ATP5F1D (ATP5D) expression was consistent with the proteomic results (Fig. 7d,
e). The expression of ATP5D was signicantly reduced in abdominal macrophages of patients with endometriosis as
compared to non-endometriosis patients (Fig. 7f). Therefore, we hypothesize that the excessive expression of miR-210-3p in
macrophages inhibits the expression of ATP5D, affecting the function of macrophages.
By knocking down ATP5D expression in macrophages, the expressions of CD206, CD163 and IL10 in macrophages were
signicantly increased, while the expressions of iNOS and CCR7 were signicantly decreased (Fig. 7g), suggesting that
inhibiting ATP5D expression drive the M2 polarization of macrophages. Subsequently, the supernatant of macrophages with
low-expression of ATP5D was co-cultured with hESCs for 48 hours, wound healing assays and transwell indicated that
macrophages with decreased expression of ATP5D remarkably enhanced the migration capacity of hESCs (Fig. 7h, i).
Discussion
Endometriosis is a common benign gynecological disease; however, its biological behavior regarding distant metastasis and
invasion is similar to that of malignant tumors[27]. The pathogenesis of endometriosis is still unclear[1, 2, 10], despite a large
body of evidence suggests that, in addition to hormonal and intrinsic abnormalities of the endometrium, the immune system
plays a key role in its development[28, 29].
Immune dysfunction is believed to play a role in both the initiation and progression of endometriosis by creating a
microenvironment that encourages the ectopic survival and implantation of endometrial cells[30, 31]. Our study has
demonstrated that the inammatory abdominal microenvironment is conducive to the implantation and growth of ectopic
endometrial cells, and that peritoneal macrophages are primarily M2 macrophages. Furthermore, we found that peritoneal
macrophages from endometriosis patients can stimulate the migration, invasion, and proliferation of hESCs while also
inducing their progesterone resistance. This evidence suggests that the changes of macrophages establish an "immune
tolerance" microenvironment locally in the abdominal cavity, providing a suitable "soil" for the implantation and growth of
ectopic lesions[32–34]. Consequently, there is a new research focus on regulating the abdominal immune microenvironment,
Page 9/22
reprogramming macrophage epigenetic, and disrupting the "peaceful coexistence" between ectopic endometrial tissue and the
local microenvironment.
Exosomes act as natural carriers of intercellular information and play a crucial role in immune regulation, particularly in remote
regulation[19]. Our results demonstrate that uterine-derived exosomes from endometriosis patients, when administered to
peritoneal macrophages, stimulate the proliferation and migration of hESCs while also inducing their resistance to
progesterone. Our earlier study revealed that miR-210-3p expression was upregulated in both uterine-derived exosomes and
eutopic endometrial tissue from women with endometriosis[26]. Our present study shows that miR-210-3p expression is
upregulated in peritoneal macrophages from women with endometriosis. Therefore, we hypothesize that exosomes from the
uterine cavity may cause the ectopic implantation and growth of endometrial cells by elevating miR-210-3p expression in
peritoneal macrophages.
In the present study, we show that upregulation of macrophage miR-210-3p inhibits ATP5D expression, thereby enhancing the
invasion and migration of hESCs. Moreover, downregulating macrophage ATP5D expression induces M2 polarization, which
may be a mechanism by which uterine-derived exosomes promote endometriosis development. ATP5D is a subunit of
mitochondrial ATP synthase that plays an important role in catalyzing the synthesis of ATP in the mitochondria[35]. Decreased
mitochondrial ATP generation typically increases AMP concentration and shifts metabolism from synthetic to catabolic[36].
The metabolic state of macrophages not only reects the intrinsic stability of the local microenvironment but also affects the
local microenvironment by altering their own function[37–40]. Therefore, exosomes derived from the uterine cavity may affect
the function of macrophages by disrupting their metabolism through the alteration of ATP synthase in peritoneal
macrophages.
Similar to the "tumor niche" hypothesis[41], the immune microenvironment of the abdomen ("soil") undergoes changes before
endometrial cells ("seeds") reach the peritoneal cavity, promoting the escape of the "seeds" from immune surveillance and
aiding in their settlement and growth. Uterine-derived exosomes may function as a mode of information transfer. In fact,
endometriotic exosomes may retrogradely enter the pelvic area and adjust local cell functions, shaping a suitable "soil" for
ectopic endometrial growth, which might be key molecules in the pathogenesis of endometriosis[42–44]. Our data suggest that
uterine-derived exosomes inhibit macrophage ATP5D expression, driving macrophages towards M2 polarization, establishing a
suitable soil of local immune inhibition and promoting ectopic endometrial settlement. Additionally, study found that exosomes
induce macrophage polarization to create a favorable microenvironment for angiogenesis, regulating the development of
endometriosis[45, 46].
Our study demonstrates that uterine-derived exosomes can regulate the expression of miR-210-3p in peritoneal macrophages to
induce the formation of an immunosuppressive microenvironment. These ndings provide new insights into the role of uterine-
derived exosomes in mediating the establishment of an immunosuppressive peritoneal microenvironment and show that miR-
210-3p may be a valuable biomarker, and that inhibiting the expression of miR-210-3p in peritoneal macrophages may become
a novel immunotherapeutic strategy for endometriosis.
However, our study has some limitations. Although the isolated extracellular vesicles from the uterus cavity may reect the
initial state of the cavity, it is hard to identify a specic source of exosomes. Because of species variation, we were unable to
directly investigate the impacts of exosomes that are derived from the uterus of endometriosis patients on the implantation
and growth of ectopic lesions and peritoneal macrophages in a mouse model. It is crucial to investigate the particular
regulatory mechanism of uterine-derived exosomes on the function of macrophages, to gain a more profound understanding of
the role they plays in the growth and metastasis of hESCs.
Conclusion
In summary, we presented evidence of the mediation of growth and migration of hESCs by exosomes derived from the uterine
cavity in endometriosis patients. We discovered that uterine-derived exosomes upregulate the expression of miR-210-3p in
Page 10/22
peritoneal macrophages to inhibit ATP5D, thereby promoting M2 polarization and reshaping the peritoneal immune
microenvironment, which leads to the development of endometriosis.
Abbreviations
EMs
Endometriosis
hESCs
Human Endometrial Stromal Cells
EMSCs
Endometrium-derived Mesenchymal Stem Cells
ATP5D
ATP synthase, H + transporting, mitochondrial F1 complex, δ subunit
PBS
Phosphate buffer saline
LPS
Lipopolysaccharide
PMA
Phorbol-12-myristate-13-acetate
WB
Western blot analysis
PR
Progesterone Receptor
ER
Estrogen Receptor
E-Ca
Epithelial Cadherin
N-Ca
Neural Cadherin
EMs-exo
exosomes from uterine uid of patients with endometriosis
Control-exo
exosomes from uterine uid of patients without endometriosis
NTA
Nanoparticle Tracking Analysis
TEM
Transmission Electron Microscope
Thp1
Human myeloid leukemia mononuclear cells
MMP
Matrix Metalloproteinase
IGFBP1
Insulin-like Growth Factor Binding Protein 1
mimics NC
Mimics negative control
Inhibitor NC
Inhibitor negative control
siRNA
Small interfering RNA
Page 11/22
GO
Gene Ontology
KEGG
Kyoto Encyclopedia of Genes
Declarations
Ethics approval and consent to participate
This study was approved by the Medical Ethics Committee of the Second Xiangya Hospital of Central South University
(approval number:2020-065). Informed consent was obtained from each patient. All animal handling and experimental
procedures were approved by the Animal Experimental Ethics Committee of the Second Xiangya Hospital of Central South
University (approval number:20220059).
Consent for publication
Not applicable
Availability of data and materials
All data produced or analyzed in this study are contained in this published article and its supplementary information les. All
data used in the current study are available from the corresponding author on reasonable request.
Competing interests
The authors declare that they have no competing interests in this work.
Funding
This study was supported by a grant from the National Natural Science Foundation of China (#81873826).
Authors' contributions
SN.C and XQ.W conceived and designed the experiments; SN.C, Y.J and XQ.W prepared the manuscript; SN.C, Y.J and XS.C
performed the experiments; ZY.C, H.T, M.L, TY.Z, WW.SG collected the samples; SN.C and XQ.W analyzed the data. All authors
read and approved the nal manuscript.
References
1. Zondervan KT, Becker CM, Missmer SA. Endometriosis. Longo DL, editor. N Engl J Med [Internet]. 2020 [cited 2023 May
31];382:1244–56. Available from: https://pubmed.ncbi.nlm.nih.gov/32212520/
2. Giudice LC, Kao LC. Endometriosis. Lancet [Internet]. 2004 [cited 2023 May 31];364:1789–99. Available from:
https://pubmed.ncbi.nlm.nih.gov/15541453/
3. Halme J, HAMMOND M, … JH-O&, 1984 undened. Retrograde menstruation in healthy women and in patients with
endometriosis. journals.lww.com [Internet]. [cited 2023 May 31]; Available from:
https://journals.lww.com/greenjournal/Abstract/1984/08000/Retrograde_Menstruation_in_Healthy_Women_and_in.1.aspx
4. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: ndings from the
National Health Interview Survey, 1984 to 1992. Am J Public Health [Internet]. 1996 [cited 2023 May 31];86:195–9.
Available from: https://pubmed.ncbi.nlm.nih.gov/8633735/
Page 12/22
5. Zhang Z, Suo L, Chen Y, Zhu L, International GW-SC, 2019 undened. Endometriotic peritoneal uid promotes
myobroblast differentiation of endometrial mesenchymal stem cells. hindawi.com [Internet]. [cited 2023 May 31];
Available from: https://www.hindawi.com/journals/sci/2019/6183796/
. Khatun M, Sorjamaa A, Kangasniemi M, Sutinen M, Salo T, Liakka A, et al. Niche matters: The comparison between bone
marrow stem cells and endometrial stem cells and stromal broblasts reveal distinct migration and cytokine proles in
response to inammatory stimulus. PLoS One [Internet]. 2017 [cited 2023 May 31];12. Available from:
https://pubmed.ncbi.nlm.nih.gov/28419140/
7. Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the rst 10 years. Hum Reprod Update [Internet].
2016 [cited 2023 May 31];22:137–63. Available from: https://pubmed.ncbi.nlm.nih.gov/26552890/
. Kao AP, Wang KH, Chang CC, Lee JN, Long CY, Chen HS, et al. Comparative study of human eutopic and ectopic
endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril
[Internet]. 2011 [cited 2023 May 31];95. Available from: https://pubmed.ncbi.nlm.nih.gov/21047634/
9. Nair ARKG, Pandit H, Warty N, Madan T. Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype. Int
Immunol [Internet]. 2015 [cited 2023 May 31];27:195–204. Available from: https://pubmed.ncbi.nlm.nih.gov/25416515/
10. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril [Internet]. 2012 [cited 2023 May
31];98:511–9. Available from: https://pubmed.ncbi.nlm.nih.gov/22819144/
11. Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ [Internet]. 2014
[cited 2023 May 31];21:216–25. Available from: https://pubmed.ncbi.nlm.nih.gov/24185619/
12. Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum
Reprod Update [Internet]. 2019 [cited 2023 May 31];25:565–92. Available from:
https://pubmed.ncbi.nlm.nih.gov/31424502/
13. Ramírez-Pavez TN, Martínez-Esparza M, Ruiz-Alcaraz AJ, Marín-Sánchez P, Machado-Linde F, García-Peñarrubia P. The Role
of Peritoneal Macrophages in Endometriosis. Int J Mol Sci [Internet]. 2021 [cited 2023 May 31];22. Available from:
https://pubmed.ncbi.nlm.nih.gov/34639133/
14. Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS. Macrophage expression in endometrium of women with
and without endometriosis. Hum Reprod [Internet]. 2009 [cited 2023 May 31];24:325–32. Available from:
https://pubmed.ncbi.nlm.nih.gov/19049988/
15. Weinberg J, Haney A, Xu F, Ramakrishnan S. Peritoneal uid and plasma levels of human macrophage colony-stimulating
factor in relation to peritoneal uid macrophage content. 1991 [cited 2023 May 31]; Available from:
https://ashpublications.org/blood/article-abstract/78/2/513/168804
1. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, et al. Macrophages are alternatively activated in
patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J
Pathol [Internet]. 2009 [cited 2023 May 31];175:547–56. Available from: https://pubmed.ncbi.nlm.nih.gov/19574425/
17. Jeljeli M, Riccio LGC, Chouzenoux S, Moresi F, Toullec L, Doridot L, et al. Macrophage Immune Memory Controls
Endometriosis in Mice and Humans. Cell Rep [Internet]. 2020 [cited 2023 May 31];33. Available from:
https://pubmed.ncbi.nlm.nih.gov/33147452/
1. Xie Q, He H, Wu YH, Zou LJ, She XL, Xia XM, et al. Eutopic endometrium from patients with endometriosis modulates the
expression of CD36 and SIRP- α in peritoneal macrophages. J Obstet Gynaecol Res [Internet]. 2019 [cited 2023 May
31];45:1045–57. Available from: https://pubmed.ncbi.nlm.nih.gov/30843336/
19. Kalluri R, LeBleu VS. The biology , function , and biomedical applications of exosomes. Science [Internet]. 2020 [cited 2023
May 31];367. Available from: https://pubmed.ncbi.nlm.nih.gov/32029601/
20. Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol [Internet].
2018 [cited 2023 May 31];35:69–79. Available from: https://pubmed.ncbi.nlm.nih.gov/29289420/
21. Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial
ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res [Internet]. 2019 [cited
2023 May 31];115:1205–16. Available from: https://pubmed.ncbi.nlm.nih.gov/30753344/
Page 13/22
22. Xin L, Lin X, Zhou F, Li C, Wang X, Yu H, et al. A scaffold laden with mesenchymal stem cell-derived exosomes for
promoting endometrium regeneration and fertility restoration through macrophage immunomodulation. Acta Biomater
[Internet]. 2020 [cited 2023 May 31];113:252–66. Available from: https://pubmed.ncbi.nlm.nih.gov/32574858/
23. Sun H, Li D, Yuan M, Li Q, Zhen Q, Li N, et al. Macrophages alternatively activated by endometriosis-exosomes contribute to
the development of lesions in mice. Mol Hum Reprod [Internet]. 2019 [cited 2023 May 31];25:5–16. Available from:
https://pubmed.ncbi.nlm.nih.gov/30428082/
24. Campoy I, Lanau L, Altadill T, Sequeiros T, Cabrera S, Cubo-Abert M, et al. Exosome-like vesicles in uterine aspirates: a
comparison of ultracentrifugation-based isolation protocols. J Transl Med [Internet]. 2016 [cited 2023 May 31];14.
Available from: https://pubmed.ncbi.nlm.nih.gov/27317346/
25. Harp D, Driss A, Mehrabi S, Chowdhury I, Xu W, Liu D, et al. Exosomes derived from endometriotic stromal cells have
enhanced angiogenic effects in vitro. Cell Tissue Res [Internet]. 2016 [cited 2023 May 31];365:187–96. Available from:
https://pubmed.ncbi.nlm.nih.gov/26841879/
2. Jiang Y, Chai X, Chen S, Chen Z, Tian H, Liu M, et al. Exosomes from the Uterine Cavity Mediate Immune Dysregulation via
Inhibiting the JNK Signal Pathway in Endometriosis. Biomedicines [Internet]. 2022 [cited 2023 May 31];10. Available from:
/pmc/articles/PMC9775046/
27. Giudice LC, Kao LC. Endometriosis. Lancet [Internet]. 2004 [cited 2023 May 31];364:1789–99. Available from:
https://pubmed.ncbi.nlm.nih.gov/15541453/
2. Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, et al. The Immunopathophysiology of Endometriosis. Trends Mol
Med [Internet]. 2018 [cited 2023 May 31];24:748–62. Available from: https://pubmed.ncbi.nlm.nih.gov/30054239/
29. Agostinis C, Balduit A, Mangogna A, Zito G, Romano F, Ricci G, et al. Immunological Basis of the Endometriosis: The
Complement System as a Potential Therapeutic Target. Front Immunol [Internet]. 2021 [cited 2023 May 31];11. Available
from: https://pubmed.ncbi.nlm.nih.gov/33505394/
30. Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell [Internet]. 2021 [cited 2023
May 31];184:2807–24. Available from: https://pubmed.ncbi.nlm.nih.gov/34048704/
31. Wang Y, Nicholes K, Shih IM. The Origin and Pathogenesis of Endometriosis. Annu Rev Pathol [Internet]. 2020 [cited 2023
May 31];15:71–95. Available from: https://pubmed.ncbi.nlm.nih.gov/31479615/
32. Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol [Internet]. 2013 [cited 2023
May 31];4. Available from: https://pubmed.ncbi.nlm.nih.gov/23372570/
33. Wu J, Xie H, Yao S, Liang Y. Macrophage and nerve interaction in endometriosis. J Neuroinammation [Internet]. 2017
[cited 2023 May 31];14. Available from: https://pubmed.ncbi.nlm.nih.gov/28288663/
34. Klemmt PA, Starzinski-Powitz A. Molecular and Cellular Pathogenesis of Endometriosis. Curr Womens Health Rev [Internet].
2018 [cited 2023 May 31];14:1–11. Available from: https://pubmed.ncbi.nlm.nih.gov/29861704/
35. Oláhová M, Yoon WH, Thompson K, Jangam S, Fernandez L, Davidson JM, et al. Biallelic Mutations in ATP5F1D, which
Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder. Am J Hum Genet [Internet]. 2018 [cited 2023 May
31];102:494–504. Available from: https://pubmed.ncbi.nlm.nih.gov/29478781/
3. Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity [Internet].
2015 [cited 2023 May 31];42:406–17. Available from: https://pubmed.ncbi.nlm.nih.gov/25786173/
37. He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, et al. Global characterization of macrophage polarization
mechanisms and identication of M2-type polarization inhibitors. Cell Rep [Internet]. 2021 [cited 2023 May 31];37.
Available from: https://pubmed.ncbi.nlm.nih.gov/34731634/
3. Verdeguer F, Aouadi M. Macrophage heterogeneity and energy metabolism. Exp Cell Res. 2017;360:35–40.
39. Yan J, Horng T. Lipid Metabolism in Regulation of Macrophage Functions. Trends Cell Biol [Internet]. 2020 [cited 2023 May
31];30:979–89. Available from: https://pubmed.ncbi.nlm.nih.gov/33036870/
40. Van den Bossche J, O’Neill LA, Menon D. Macrophage Immunometabolism: Where Are We (Going)? Trends Immunol
[Internet]. 2017 [cited 2023 May 31];38:395–406. Available from: https://pubmed.ncbi.nlm.nih.gov/28396078/
Page 14/22
41. Liu Y, Cao X. Characteristics and Signicance of the Pre-metastatic Niche. Cancer Cell [Internet]. 2016 [cited 2023 May
31];30:668–81. Available from: https://pubmed.ncbi.nlm.nih.gov/27846389/
42. Horne AW, Saunders PTK. SnapShot: Endometriosis. Cell [Internet]. 2019 [cited 2023 May 31];179:1677-1677.e1. Available
from: https://pubmed.ncbi.nlm.nih.gov/31951524/
43. Sun H, Li D, Yuan M, Li Q, Li N, Wang G. Eutopic stromal cells of endometriosis promote neuroangiogenesis via exosome
pathway † . Biol Reprod [Internet]. 2019 [cited 2023 May 31];100:649–59. Available from:
https://pubmed.ncbi.nlm.nih.gov/30295741/
44. Qiu JJ, Lin XJ, Zheng TT, Tang XY, Zhang Y, Hua KQ. The Exosomal Long Noncoding RNA aHIF is Upregulated in Serum
From Patients With Endometriosis and Promotes Angiogenesis in Endometriosis. Reprod Sci [Internet]. 2019 [cited 2023
May 31];26:1590–602. Available from: https://pubmed.ncbi.nlm.nih.gov/30808247/
45. Sun H, Li D, Yuan M, Li Q, Zhen Q, Li N, et al. Macrophages alternatively activated by endometriosis-exosomes contribute to
the development of lesions in mice. Mol Hum Reprod [Internet]. 2019 [cited 2023 May 31];25:5–16. Available from:
https://pubmed.ncbi.nlm.nih.gov/30428082/
4. Li Y, Lyu P, Ze Y, Li P, Zeng X, Shi Y, et al. Exosomes derived from plasma: promising immunomodulatory agents for
promoting angiogenesis to treat radiation-induced vascular dysfunction. PeerJ [Internet]. 2021 [cited 2023 May 31];9.
Available from: https://pubmed.ncbi.nlm.nih.gov/33859878/
Figures
Page 15/22
Figure 1
Abdominal inammatory microenvironment promotes the development of endometriosis
(a) Representative endometriosis-like lesions in the indicated treatment groups. (b)HE staining of ectopic endometrial tissues.
(c)Total volume and number of lesions (n=7), the volume is the sum of the volumes of all lesions per mouse.
(d)Immunouorescent staining of Ki-67 (red) and vimentin (green) in representative lesions. (e-f) Peritoneal macrophages were
identied by ow cytometry in the indicated treatment groups. Data are presented as mean ± SD. *P < 0.05, **P < 0.01, ***P <
0.001, ****P < 0.0001. S = stroma, E = epithelium, G = gland.
Page 16/22
Figure 2
Peritoneal macrophages promote the proliferation and migration of hESCs
(a) Wound healing assay results showing the differences in migration capacities in hESCs(left), statistical analysis of the
wound healing assay results (right). (b) Representative transwell results comparing the effects of macrophages on cell
migration between the Control and EMs groups(left), statistical analysis of the transwell assay results(right). (c, d) Protein
expression of MMP9, MMP2 and N-Cadherin in hESCs, treatment without E2 and P4, as determined by Western blotting.
GAPDH was used as a loading control. (e) CD140b+CD146+ cell count by ow cytometry (left); statistical analysis of ow
Results
(right). (f) Representative images of the colony formation assay in the indicated cells (left); statistical analysis of the
colony formation results(right). (g)Western blotting analysis of the expression of PR, N-cadherin and E-cadherin in hESCs after
induced decidualization in vitro. (h)Expression of IGFBP1 in supernatant of hESCs after induced decidualization in vitro. *P <
0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. EMs = endometriosis, Con = Control.
Page 17/22
Figure 3
The effect of macrophages treated with exosomes on hESCs
(a, b, c, d) The invasion and migration of hESCs after treatment with macrophage-conditioned medium by wound healing assay
(a), transwell (b) and protein expression of MMP9, MMP2 and N-Cadherin detected by Western blotting (c, d) in the indicated
treatment groups. (e, f) hESCs proliferative after treatment with macrophage-conditioned medium by ow cytometry(e) and
colony formation assay(f) in the indicated treatment groups. g, h hESCs progesterone resistance after treatment with
macrophage-conditioned medium by the levels of IGFBP1 detected by enzyme-linked immunosorbent assay kit (h), and protein
expression of PR , E-cadherin N-cadherin detected by Western blotting (g). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Page 18/22
Figure 4
miR-210-3p is overexpressed in macrophages treated with EMs-exo
(a)Transmission electron microscopy image of the morphology of exosomes in uterine uid (scale bar = 0.5 μ m).
(b)Nanoparticle tracking analysis result on the size distribution of uterine uid-derived exosomes. (c)Western blot analysis of
exosome positive markers CD63, HSP70 and TSG101. (d)Representative images of PKH67-labelled exosomes co-cultured with
Thp1. (e,f) The Volcano plot of the differentially expressed miRNAs in uterine-derived exosomes and eutopic endometrium from
the EMs compared with the control. (g) qRT-PCR assay of miR-210-3p expression in peritoneal uid macrophages of patients
with endometriosis (EMs, n=4) and patients without endometriosis (Control, n=4). (h) qRT-PCR assay of miR-210-3p expression
in Thp1 co-cultured with EMs-exo and Control-exo. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Page 19/22
Figure 5
miR-210-3p promotes the proliferation and migration of hESCs in vitro
(a, b, c, d) Wound healing assay (a), Transwell (b) and expression of MMP9, MMP2 and N-Cadherin (c, d) comparing the effects
of macophages on cell migration between the miR-inhibitor NC and miR-210-3p inhibitor groups. (e, f) Flow cytometry (e) and
colony formation assay(f) results showing the differences in proliferation capacities in the indicated group. (g, h) Effect of miR-
210-3p expression in macrophages on decidualization of hESCs as determined by the expression of PR, E-cadherin and N-
cadherin (g) and the levels of IGFBP1 (h).*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Page 20/22
Figure 6
miR-210-3p promotes the proliferation and migration of hESCs in vivo
(a) Schematic of experimental timeline and procedures. 24-48 hours before modeling, 150 μ l of liposomes were injected into the
mouse peritoneal cavity to deplete the original macrophages, followed by a maintenance dose of 100 μ l biweekly. RAW264.7
cells, 1 × 106 per transfer, were transferred every three days. (b, c) Representative images of ectopic endometriotic lesions in the
indicated treatment groups (b) and the HE staining of ectopic endometrial tissues (c). (d)Total volume and number of lesions in
the indicated groups (n = 6). (e) Immunouorescent staining of Ki-67 (red) and vimentin (green) in representative lesions. *P <
0.05.
Page 21/22
Figure 7
miR-210-3p induces M2 macrophage polarization by ATP5D
(a, b) The Volcano plot of the differentially expressed proteins between the indicated group. (c) The Venn diagram shows
proteins in the indicated groups with corresponding expression trends. (d) qRT-PCR analyses to verify the expression of
differential proteins with corresponding expression trends. (e) Protein expression of ATP5D in the indicated cells as determined
by Western blotting. (f) Western blot analysis of ATP5D in peritoneal macrophages from patients with endometriosis and non-
endometriosis patients. (n=10). (g)qRT-PCR analysis of M1/M2 markers in the indicated infected cells. (h, i) hESCs invasion
and migration after treatment with macrophage-conditioned medium by transwell (H) and wound healing assay (I) in the
indicated treatment groups.*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Supplementary Files
This is a list of supplementary les associated with this preprint. Click to download.
Page 22/22
SupplementalFig1.tif
SupplementalFig2.tif
SupplementalFig3.tif
SupplementaryMaterial..docx
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.